Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cordis, Elixir, Exact, Jupiter, Medtronic, Penumbra, Quest.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditxt, Alcon, Venus Medtech, Co-Diagnostics, Laplace Interventional, Orchestra, QT Imaging, Remedy Robotics, Staar.
Sustaining healthy weight loss is about so much more than cutting calories or injecting drugs, as many GLP-1 users are finding out. Withings SA continues to expand its obesity care management ecosystem and the capabilities of its connected scale to support patients through their weight loss journey and their lives after reaching goal, potentially addressing the vexing problem of patients rapidly regaining all – and often more – weight once they discontinue the drugs.
Mode Sensors AS received U.S. FDA 510(k) clearance for its Re:Balans hydration monitoring system. The wearable patch sensor allows for the continuous monitoring of body hydration to detect fluid imbalances using thoracic bioimpedance technology to deliver automatic, accurate data to help physicians in fluid management.
India’s Central Drugs Standard Control Organization (CDSCO) posted a draft guidance for medical device software, providing some clarity about the agency’s expectations for this class of products even if it seems to break no new ground.
Staar Surgical Co. reported on Oct. 24 that it had adjourned its special meeting of stockholders scheduled in connection with its proposed $1.5 billion sale to Alcon AG in the face of objections from some of its major shareholders and at least three proxy firms.
RSS
